DrugPatentWatch Database Preview
Details for Patent: 8,536,150
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which drugs does patent 8,536,150 protect, and when does it expire?
Patent 8,536,150 protects LEXISCAN and is included in one NDA.
This patent has four patent family members in three countries.
Summary for Patent: 8,536,150
Title: | Methods of myocardial perfusion imaging |
Abstract: | The present invention provides a method of myocardial perfusion imaging using reduced doses of (1-{9-[(4S,2R,3R,5R)3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopu- rin-2-yl}pyrazol-4-yl)-N-methylcarboxamide. |
Inventor(s): | Belardinelli; Luiz (Palo Alto, CA), Blackburn; Brent K. (Los Altos, CA), Gao; Zhenhai (San Jose, CA) |
Assignee: | Gilead Sciences, Inc. (Foster City, CA) |
Application Number: | 13/525,223 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 8,536,150
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astellas | LEXISCAN | regadenoson | SOLUTION;INTRAVENOUS | 022161-001 | Apr 10, 2008 | RX | Yes | Yes | Start Trial | Start Trial | METHOD OF MYOCARDIAL IMAGING | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,536,150
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 3866501 | Start Trial | |||
Canada | 2439222 | Start Trial | |||
Canada | 2671940 | Start Trial | |||
World Intellectual Property Organization (WIPO) | 0162979 | Start Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |